Latest / Decera Clinical Education Oncology Podcast
PARP Inhibitors in Metastatic Prostate Cancer: Biomarker Testing, Treatment Strategies, and Toxicity Management
In this podcast episode, Neeraj Agarwal, MD, FASCO, and Emmanuel S. Antonarakis, MD, discuss the evolving role of PARP inhibitors in metastatic prostate cancer, emphasizing early molecular testing to identify appropriate patients for PARP-directed therapy and proactive adverse event management to support treatment continuation, including:
HRR alterations and the mechanism of action of PARP inhibitors
Germline and somatic genomic testing and practical considerations for tissue and ctDNA testing
PARP inhibitor monotherapy and combination strategies, including data from AMPLITUDE and TALAPRO-3…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.